SCHEMBL7985665

SCHEMBL7985665

CC(C)CCNc1ccc(C(=O)O)c(NC(=O)C(=O)O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 6/20 0.43
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
PLK1 P53350 1/20 0.41
PTPRC P08575 2/20 0.40
PTPN2 P17706 2/20 0.40
PTPRB P23467 2/20 0.40
PTPRE P23469 2/20 0.40
PTPN6 P29350 2/20 0.40
PTPRA P18433 2/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
ADORA2A P29274 1/20 0.39
PTPRF P10586 1/20 0.39
GRIK1 P39086 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
KDM6B O15054 1/20 0.37
KDM4C Q9H3R0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985611 0.76 PTPN1 (0.52) PTPN1KDM4EALDH1A1MEN1KMT2A
SCHEMBL7984956 0.75 KDM4C (0.49) PTPN1RAB9ASMN1; SMN2NPC1PTPRC
SCHEMBL7988968 0.73 LMNA (0.47) SMN1; SMN2KDM4EKMT2A
SCHEMBL16696023 0.72 KDM4E (0.57) RAB9ASMN1; SMN2KDM4EALDH1A1GRIK1
SCHEMBL16696078 0.72 APEX1 (0.51) KDM4EALDH1A1GRIK1MEN1KMT2A
SCHEMBL8585717 0.72 KMT2A (0.53) RAB9ASMN1; SMN2NPC1KDM4EALDH1A1
SCHEMBL11310654 0.71 PLK1 (0.44) SMN1; SMN2PLK1ALDH1A1MEN1KMT2A
SCHEMBL7706906 0.71 ALDH1A1 (0.63) RAB9ASMN1; SMN2NPC1PLK1KDM4E
SCHEMBL14558287 0.71 MPO (0.41) RAB9ASMN1; SMN2PLK1KDM4EALDH1A1
SCHEMBL7848417 0.70 PTPN1 (0.56) PTPN1NPC1PTPRCPTPN2PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1062199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2000-12-27 EP claimed
WO-1999046236-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO claimed
US-6225329-B1 USEFUL IN THE TREATMENT OF TYPE I DIABETES, TYPE II DIABETES, IMPAIRED GLUCOSE TOLERANCE, INSULIN AUTOIMMUNITY DISEASES WITH DYSFUNCTIONS OF THE COAGULATION SYSTEM, ALLERGIC DISEASES NOVO NORDISK A/S (DK) 2001-05-01 US disclosed
EP-1062199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2000-12-27 EP disclosed
WO-1999046236-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed